EE200200171A - Polümorfne sool - Google Patents

Polümorfne sool

Info

Publication number
EE200200171A
EE200200171A EEP200200171A EEP200200171A EE200200171A EE 200200171 A EE200200171 A EE 200200171A EE P200200171 A EEP200200171 A EE P200200171A EE P200200171 A EEP200200171 A EE P200200171A EE 200200171 A EE200200171 A EE 200200171A
Authority
EE
Estonia
Prior art keywords
polymorphic salt
polymorphic
salt
Prior art date
Application number
EEP200200171A
Other languages
English (en)
Estonian (et)
Inventor
Bentley Arthur
Arnold Howard-Field Simon
James Ogilvie Ronald
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of EE200200171A publication Critical patent/EE200200171A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200200171A 1999-09-28 2000-09-14 Polümorfne sool EE200200171A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922963.5A GB9922963D0 (en) 1999-09-28 1999-09-28 Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en) 1999-09-28 2000-09-14 Polymorphic salt

Publications (1)

Publication Number Publication Date
EE200200171A true EE200200171A (et) 2003-06-16

Family

ID=10861767

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200171A EE200200171A (et) 1999-09-28 2000-09-14 Polümorfne sool

Country Status (50)

Country Link
US (1) US6369094B1 (de)
EP (1) EP1233960B1 (de)
JP (1) JP3795395B2 (de)
KR (1) KR100479897B1 (de)
CN (1) CN1155594C (de)
AP (1) AP2004A (de)
AR (1) AR025779A1 (de)
AT (1) ATE246185T1 (de)
AU (1) AU779580B2 (de)
BG (1) BG65161B1 (de)
BR (1) BR0014272A (de)
CA (1) CA2379572C (de)
CO (1) CO5180567A1 (de)
CR (1) CR6561A (de)
CU (1) CU23200A3 (de)
CZ (1) CZ2002971A3 (de)
DE (1) DE60004262T2 (de)
DK (1) DK1233960T3 (de)
DZ (1) DZ3254A1 (de)
EA (1) EA004510B1 (de)
EE (1) EE200200171A (de)
EG (1) EG24143A (de)
ES (1) ES2200911T3 (de)
GB (1) GB9922963D0 (de)
GE (1) GEP20043365B (de)
GT (1) GT200000159A (de)
HK (1) HK1048628B (de)
HR (1) HRP20020270B1 (de)
HU (1) HUP0202821A3 (de)
IL (1) IL147154A (de)
IS (1) IS2162B (de)
MA (1) MA26821A1 (de)
MX (1) MXPA02003311A (de)
MY (1) MY121170A (de)
NO (1) NO321936B1 (de)
NZ (1) NZ516093A (de)
OA (1) OA12024A (de)
PA (1) PA8498901A1 (de)
PE (1) PE20010662A1 (de)
PL (1) PL354960A1 (de)
PT (1) PT1233960E (de)
SI (1) SI1233960T1 (de)
SK (1) SK3982002A3 (de)
TN (1) TNSN00187A1 (de)
TR (1) TR200200804T2 (de)
TW (1) TWI265926B (de)
UA (1) UA72272C2 (de)
WO (1) WO2001023377A2 (de)
YU (1) YU2602A (de)
ZA (1) ZA200202406B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
EP1819323B2 (de) * 2004-12-03 2023-03-22 Merck Sharp & Dohme Corp. Pharmazeutische zusammensetzung mit anti-keimbildner
CA2625918A1 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
KR100814109B1 (ko) * 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
IN2012DN03377A (de) 2009-10-26 2015-10-23 Merck Sharp & Dohme

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
PL170330B1 (pl) * 1990-10-15 1996-11-29 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
PL337803A1 (en) 1997-07-03 2000-09-11 Pfizer Pharmaceutic agents containing eletriptane hemisulphate and caffeine

Also Published As

Publication number Publication date
MY121170A (en) 2005-12-30
CO5180567A1 (es) 2002-07-30
KR20020032627A (ko) 2002-05-03
ES2200911T3 (es) 2004-03-16
AP2002002457A0 (en) 2002-06-30
NO20021525D0 (no) 2002-03-26
OA12024A (en) 2006-04-19
GEP20043365B (en) 2004-05-10
TNSN00187A1 (fr) 2005-11-10
HRP20020270B1 (en) 2004-04-30
JP2003510318A (ja) 2003-03-18
IS2162B (is) 2006-11-15
YU2602A (sh) 2004-11-25
EP1233960B1 (de) 2003-07-30
EP1233960A2 (de) 2002-08-28
AU6721300A (en) 2001-04-30
HRP20020270A2 (en) 2003-06-30
PE20010662A1 (es) 2001-06-23
IS6223A (is) 2002-01-08
NZ516093A (en) 2005-01-28
TWI265926B (en) 2006-11-11
BR0014272A (pt) 2002-05-21
US6369094B1 (en) 2002-04-09
CN1155594C (zh) 2004-06-30
HUP0202821A3 (en) 2003-12-29
ATE246185T1 (de) 2003-08-15
IL147154A (en) 2005-11-20
WO2001023377A2 (en) 2001-04-05
GT200000159A (es) 2002-03-20
CN1364166A (zh) 2002-08-14
BG65161B1 (bg) 2007-04-30
SK3982002A3 (en) 2003-05-02
MA26821A1 (fr) 2004-12-20
CA2379572C (en) 2006-11-14
CR6561A (es) 2005-04-04
UA72272C2 (uk) 2005-02-15
EA200200302A1 (ru) 2002-10-31
AR025779A1 (es) 2002-12-11
CZ2002971A3 (cs) 2003-04-16
AP2004A (en) 2009-06-10
GB9922963D0 (en) 1999-12-01
MXPA02003311A (es) 2002-10-04
NO321936B1 (no) 2006-07-24
WO2001023377A3 (en) 2002-03-07
DE60004262T2 (de) 2004-01-22
PA8498901A1 (es) 2004-02-07
HK1048628B (zh) 2004-10-21
DE60004262D1 (de) 2003-09-04
AU779580B2 (en) 2005-01-27
HUP0202821A2 (hu) 2003-01-28
ZA200202406B (en) 2003-05-28
EG24143A (en) 2008-08-06
PL354960A1 (en) 2004-03-22
BG106240A (en) 2002-07-31
DK1233960T3 (da) 2003-10-27
NO20021525L (no) 2002-03-26
WO2001023377A9 (en) 2002-03-28
HK1048628A1 (en) 2003-04-11
DZ3254A1 (fr) 2001-04-05
JP3795395B2 (ja) 2006-07-12
SI1233960T1 (en) 2003-12-31
CU23200A3 (es) 2007-04-06
PT1233960E (pt) 2003-11-28
CA2379572A1 (en) 2001-04-05
TR200200804T2 (tr) 2002-07-22
IL147154A0 (en) 2002-08-14
KR100479897B1 (ko) 2005-03-31
EA004510B1 (ru) 2004-04-29

Similar Documents

Publication Publication Date Title
NO20000885D0 (no) 4-Fenyl-pyridin-derivater
NO20021077D0 (no) Amino-triazolopyridin-derivater
DE50010060D1 (de) Thiazolylamid-derivate
ATE263748T1 (de) Admantan-derivate
EE200100502A (et) Ühendid
IS6128A (is) 13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
NO20021803D0 (no) Isoksazolkarboksamid-derivater
ATE257148T1 (de) Propargyletherderivate
ATE374747T1 (de) Monofluoralkylderivate
DK1154988T3 (da) Mevinolinderivater
ATE293592T1 (de) Resorcinderivate
EE200200171A (et) Polümorfne sool
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
PT1088818E (pt) Derivados de quinolin-4-ilo
DE60024023D1 (de) Nockenwellenversteller
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no) Syklopentenon-derivater
PT1194401E (pt) Derivados de diacil-hidrazina
DK1178984T3 (da) 1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
ATE269328T1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
FIU990399U0 (fi) Perhouistin vapakalastukseen